KalVista is a pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet needs.
|Data provided by Nasdaq. Minimum 15 minutes delayed. |
View Attributions and Sources
January 05, 2018KalVista Pharmaceuticals Commences Two Clinical Trials
December 14, 2017KalVista Pharmaceuticals Reports Fiscal Second Quarter Results
November 08, 2017KalVista Pharmaceuticals to Present at Stifel Healthcare ConferenceMore News